£ACWI
Fondas siekia kuo tiksliau atkartoti MSCI ACWI (All Country World Index) indekso rezultatus.
Vardas ar pavadinimas | Svoris | Rinkos kapitalizacija | Kaina | Dienos pokytis |
|---|---|---|---|---|
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Legend Biotech $LEGNSveikata | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
bioMérieux S.A. €BIMSveikata | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Oneok $OKEEnergetika | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Verisure P.L.C. €VSURE | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Rational €RAAPramonė | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
L E Lundbergföretagen AB Skr LUND BFinansai | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Sofina Société Anonyme €SOFFinansai | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A |